Generic and biosimilar medicines: quid?

Authors

  • Steven Simoens Department of Pharmaceutical and Pharmacological Sciences, KU Leuven

DOI:

https://doi.org/10.7175/fe.v13i3S.448

Keywords:

Generic medicine, Biosimilars

Abstract

Once intellectual property protection, data and marketing exclusivity of reference medicines have expired, generic medicines and biosimilar medicines can enter the off-patent market. This market entry is conditional on the approval of marketing authorization, pricing and reimbursement. Given that there tends to be confusion surrounding generic and biosimilar medicines, this Editorial introduces basic concepts related to generic and biosimilar medicines and presents the different studies and articles included in this supplement dedicated to generic and biosimilar medicines.

Downloads

Published

2012-12-05

Issue

Vol. 13 No. 3S (2012)

Section

Editorial

License

>> DISTRIBUTION / LICENSE <<

 

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. The Publication Agreement can be downloaded here, and should be signed by the Authors and sent to the Publisher when the article has been accepted for publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).
  4. Authors are permitted to post their work online after publication (the article must link to publisher version, in html format)

How to Cite

Generic and biosimilar medicines: quid?. (2012). Farmeconomia. Health Economics and Therapeutic Pathways, 13(3S), 3-4. https://doi.org/10.7175/fe.v13i3S.448